Literature DB >> 10820245

Cooperation among Stat1, glucocorticoid receptor, and PU.1 in transcriptional activation of the high-affinity Fc gamma receptor I in monocytes.

S Aittomäki1, M Pesu, B Groner, O A Jänne, J J Palvimo, O Silvennoinen.   

Abstract

IFN-gamma and glucocorticoids regulate inflammatory and immune responses through Stat1 and glucocorticoid receptor (GR) transcription factors, respectively. The biological responses to these polypeptides are determined by integration of various signaling pathways in a cell-type and promoter-dependent manner. In this study we have characterized the molecular basis for the functional cooperation between IFN-gamma and dexamethasone (Dex) in the induction of the high-affinity Fc gamma receptor I (Fc gamma RI) in monocytes. Dex did not affect IFN-gamma-induced Stat1 DNA binding activity or induce novel DNA-binding complexes to the Fc gamma RI promoter. By using cell systems lacking functional GR or Stat1, we showed that GR stimulated Stat1-dependent transcription in a ligand-dependent manner, while Stat1 did not influence GR-dependent transcription. The cooperation required phosphorylation of Tyr701, DNA binding, and the trans-activation domain of Stat1, but did not involve Ser727 phosphorylation of Stat1 or physical interaction between GR and Stat1. The costimulatory effect of Dex was not dependent on a consensus glucocorticoid response element in the Stat1-responsive promoters, but required the DNA-binding and trans-activation functions of GR, and Dex-induced protein synthesis. GR activated the natural Fc gamma RI promoter construct, and this response required both Stat1 and the Ets family transcription factor PU.1. Previously, physical association between GR and Stat5 has been shown to enhance Stat5-dependent and suppress GR-dependent transcription. The results shown here demonstrate a distinct, indirect mechanism of cross-modulation between cytokine and steroid receptor signaling that integrates Stat1 and GR pathways with cell type-specific PU.1 transcription factor in the regulation of Fc gamma RI gene transcription.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10820245     DOI: 10.4049/jimmunol.164.11.5689

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

1.  Signal transducer and activator of transcription 1 negatively regulates constitutive gamma interferon-inducible lysosomal thiol reductase expression.

Authors:  Priya Srinivasan; Maja Maric
Journal:  Immunology       Date:  2010-10-13       Impact factor: 7.397

2.  The type I interferon signaling pathway is a target for glucocorticoid inhibition.

Authors:  Jamie R Flammer; Jana Dobrovolna; Megan A Kennedy; Yurii Chinenov; Christopher K Glass; Lionel B Ivashkiv; Inez Rogatsky
Journal:  Mol Cell Biol       Date:  2010-08-02       Impact factor: 4.272

3.  Stat1-vitamin D receptor interactions antagonize 1,25-dihydroxyvitamin D transcriptional activity and enhance stat1-mediated transcription.

Authors:  Marcos Vidal; Chilakamarti V Ramana; Adriana S Dusso
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

4.  Glucocorticoids target suppressor of cytokine signaling 1 (SOCS1) and type 1 interferons to regulate Toll-like receptor-induced STAT1 activation.

Authors:  Sandip Bhattacharyya; Yuxing Zhao; Thomas W H Kay; Louis J Muglia
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-23       Impact factor: 11.205

Review 5.  Cytokine-effects on glucocorticoid receptor function: relevance to glucocorticoid resistance and the pathophysiology and treatment of major depression.

Authors:  Thaddeus W W Pace; Fang Hu; Andrew H Miller
Journal:  Brain Behav Immun       Date:  2006-10-27       Impact factor: 7.217

6.  Severe asthma in humans and mouse model suggests a CXCL10 signature underlies corticosteroid-resistant Th1 bias.

Authors:  Marc Gauthier; Krishnendu Chakraborty; Timothy B Oriss; Mahesh Raundhal; Sudipta Das; Jie Chen; Rachael Huff; Ayan Sinha; Merritt Fajt; Prabir Ray; Sally E Wenzel; Anuradha Ray
Journal:  JCI Insight       Date:  2017-07-06

7.  JAK2 V617F-dependent upregulation of PU.1 expression in the peripheral blood of myeloproliferative neoplasm patients.

Authors:  Tamotsu Irino; Munehiro Uemura; Humitsugu Yamane; Shigeto Umemura; Takahiko Utsumi; Naoki Kakazu; Taku Shirakawa; Mitsuhiro Ito; Takayo Suzuki; Kazuo Kinoshita
Journal:  PLoS One       Date:  2011-07-18       Impact factor: 3.240

8.  Zebrafish whole-adult-organism chemogenomics for large-scale predictive and discovery chemical biology.

Authors:  Siew Hong Lam; Sinnakarupan Mathavan; Yan Tong; Haixia Li; R Krishna Murthy Karuturi; Yilian Wu; Vinsensius B Vega; Edison T Liu; Zhiyuan Gong
Journal:  PLoS Genet       Date:  2008-07-11       Impact factor: 5.917

9.  Reduced levels of CCL2 and CXCL10 in systemic lupus erythematosus patients under treatment with prednisone, mycophenolate mofetil, or hydroxychloroquine, except in a high STAT1 subset.

Authors:  Paul R Dominguez-Gutierrez; Angela Ceribelli; Minoru Satoh; Eric S Sobel; Westley H Reeves; Edward K L Chan
Journal:  Arthritis Res Ther       Date:  2014-01-24       Impact factor: 5.156

10.  Interactions between inflammatory mediators and corticosteroids regulate transcription of genes within the Kynurenine Pathway in the mouse hippocampus.

Authors:  Alexandra K Brooks; Marcus A Lawson; Robin A Smith; Tiffany M Janda; Keith W Kelley; Robert H McCusker
Journal:  J Neuroinflammation       Date:  2016-05-03       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.